DK1189615T3 - Endoparasiticide synergistic combination containing cyclic depsipeptides and piperazines - Google Patents

Endoparasiticide synergistic combination containing cyclic depsipeptides and piperazines

Info

Publication number
DK1189615T3
DK1189615T3 DK00940235T DK00940235T DK1189615T3 DK 1189615 T3 DK1189615 T3 DK 1189615T3 DK 00940235 T DK00940235 T DK 00940235T DK 00940235 T DK00940235 T DK 00940235T DK 1189615 T3 DK1189615 T3 DK 1189615T3
Authority
DK
Denmark
Prior art keywords
piperazines
endoparasiticide
depsipeptides
cyclic depsipeptides
containing cyclic
Prior art date
Application number
DK00940235T
Other languages
Danish (da)
Inventor
Achim Harder
Samson-Himmelstjerna Georg Von
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7907825&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1189615(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Application granted granted Critical
Publication of DK1189615T3 publication Critical patent/DK1189615T3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15Depsipeptides; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

The invention relates to the use of piperazines for potentiating the endoparasiticidal action of cyclic depsipeptides in endoparasiticidal agents. Said depsipeptides are comprised of amino acids and hydroxycarboxylic acids serving as ring structural elements and having 24 ring atoms. The invention also relates to agents of this type and to the use of piperazines and cyclic depsipeptides, said depsipeptides being comprised of amino acids and hydroxycarboxylic acids serving as ring structural elements and having 24 ring atoms, in order to produce endoparasiticidal agents.
DK00940235T 1999-05-12 2000-05-04 Endoparasiticide synergistic combination containing cyclic depsipeptides and piperazines DK1189615T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19921887A DE19921887A1 (en) 1999-05-12 1999-05-12 Synergistic ectoparasiticide combination for use in human or veterinary medicine, comprising cyclic depsipeptide and piperazine compound as potentiating agent

Publications (1)

Publication Number Publication Date
DK1189615T3 true DK1189615T3 (en) 2004-06-07

Family

ID=7907825

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00940235T DK1189615T3 (en) 1999-05-12 2000-05-04 Endoparasiticide synergistic combination containing cyclic depsipeptides and piperazines

Country Status (26)

Country Link
EP (1) EP1189615B1 (en)
JP (1) JP2002544224A (en)
KR (1) KR100704717B1 (en)
CN (1) CN1224391C (en)
AT (1) ATE258795T1 (en)
AU (1) AU768910B2 (en)
BR (1) BR0010499A (en)
CA (1) CA2373827C (en)
CZ (1) CZ300782B6 (en)
DE (2) DE19921887A1 (en)
DK (1) DK1189615T3 (en)
ES (1) ES2211558T3 (en)
HK (1) HK1047228B (en)
HR (1) HRP20010918B1 (en)
HU (1) HUP0201201A3 (en)
MX (1) MXPA01011455A (en)
NO (1) NO328870B1 (en)
PL (1) PL200951B1 (en)
PT (1) PT1189615E (en)
RS (1) RS50169B (en)
RU (1) RU2250779C2 (en)
SK (1) SK285494B6 (en)
TR (2) TR200103240T2 (en)
UA (1) UA72520C2 (en)
WO (1) WO2000069425A2 (en)
ZA (1) ZA200108238B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10008128A1 (en) * 2000-02-22 2001-08-23 Bayer Ag Endoparasiticide composition effective on topical administration, comprises solution of depsipeptide in solvent such as 1,2-isopropylidene-glycerol
DE10358525A1 (en) * 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasiticides Means for topical application
KR101671325B1 (en) * 2015-01-09 2016-11-02 한국생명공학연구원 Novel cyclic depsipeptide-based compound, separation method thereof, and antibacterial pharmaceutical composition containing the same as an active ingredient
LT3298027T (en) 2015-05-20 2021-08-10 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
SG11201805368YA (en) * 2015-12-28 2018-07-30 Merial Inc Anthelmintic depsipeptide compounds
WO2018093920A1 (en) 2016-11-16 2018-05-24 Merial, Inc. Anthelmintic depsipeptide compounds
US20230339874A1 (en) * 2020-09-11 2023-10-26 The Governing Council Of The University Of Toronto Piperazinyl compounds and methods for treating nematode infections

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA842571B (en) * 1983-04-07 1985-11-27 Merck & Co Inc Novel synergistic antiparasitic combinations
JPS6471865A (en) * 1987-09-11 1989-03-16 Nichibai Boeki Kk 1-alkylcarbamoyl-4-methylpiperazine derivative
NO176766C (en) * 1989-02-07 1995-05-24 Meiji Seika Kaisha Process for the preparation of a compound having anthelmintic activity
AU686222B2 (en) * 1993-09-06 1998-02-05 Astellas Pharma Inc. Cyclodepsipeptide compound
DE4400464A1 (en) * 1994-01-11 1995-07-13 Bayer Ag Endoparasiticidal agents
DE19520275A1 (en) * 1995-06-02 1996-12-05 Bayer Ag Endoparasiticidal agents
AU6860296A (en) * 1995-09-07 1997-03-27 Pharmacia & Upjohn Company Cycloanthelmintic inhibitors
AU6229898A (en) * 1997-02-19 1998-09-09 Bayer Aktiengesellschaft Derivatives of cyclodepsipeptide, pf1022 substance
JP2002502398A (en) * 1997-06-04 2002-01-22 バイエル・アクチエンゲゼルシヤフト Desoxycyclodepsipeptide and its use for controlling endoparasites
US6288038B1 (en) * 1998-08-04 2001-09-11 Nisshin Seifun Group Inc. Depsipeptide derivatives bearing piperazinone rings

Also Published As

Publication number Publication date
HUP0201201A3 (en) 2003-03-28
ZA200108238B (en) 2002-12-24
RS50169B (en) 2009-05-06
YU80501A (en) 2004-09-03
CA2373827C (en) 2008-09-16
HUP0201201A2 (en) 2002-08-28
NO20015398L (en) 2001-11-05
EP1189615A2 (en) 2002-03-27
TR200401875T2 (en) 2005-01-24
CA2373827A1 (en) 2000-11-23
HK1047228A1 (en) 2003-02-14
DE19921887A1 (en) 2000-11-16
JP2002544224A (en) 2002-12-24
HRP20010918A2 (en) 2003-04-30
CN1352559A (en) 2002-06-05
AU5523700A (en) 2000-12-05
KR100704717B1 (en) 2007-04-09
WO2000069425A2 (en) 2000-11-23
MXPA01011455A (en) 2002-07-30
RU2250779C2 (en) 2005-04-27
TR200103240T2 (en) 2002-04-22
AU768910B2 (en) 2004-01-08
HK1047228B (en) 2006-07-21
WO2000069425A3 (en) 2001-03-15
NO328870B1 (en) 2010-06-07
SK16262001A3 (en) 2002-03-05
DE50005213D1 (en) 2004-03-11
PL351376A1 (en) 2003-04-07
CZ300782B6 (en) 2009-08-12
UA72520C2 (en) 2005-03-15
HRP20010918B1 (en) 2011-01-31
SK285494B6 (en) 2007-02-01
CZ20014060A3 (en) 2002-06-12
ES2211558T3 (en) 2004-07-16
ATE258795T1 (en) 2004-02-15
KR20010109527A (en) 2001-12-10
EP1189615B1 (en) 2004-02-04
CN1224391C (en) 2005-10-26
PL200951B1 (en) 2009-02-27
PT1189615E (en) 2004-05-31
BR0010499A (en) 2002-02-13
NO20015398D0 (en) 2001-11-05

Similar Documents

Publication Publication Date Title
ATE383169T1 (en) COMPONENT AND COMPOSITIONS FOR ADMINISTRATION OF ACTIVE INGREDIENTS
TR200201874T2 (en) New compounds and compositions as protease inhibitors.
CY1108610T1 (en) IL-2 Peptides and their derivatives and their use as therapeutic agents
ATE257386T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING A MIXTURE OF SELF-CROSS-LINKED AND NON-SELF-CROSS-LINKED HYALURONIC ACID FOR THE TREATMENT OF ARTHROPATHIES
TR200002759T2 (en) Cabergoline use in the treatment of leg numbness syndrome.
TR200103428T2 (en) IMPDH enzyme inhibitors.
ES2162231T3 (en) NEW DERIVATIVES OF N- (ARILSULFONIL) AMINO ACIDS THAT HAVE AFFINITY WITH THE BRADICININE RECEPTORS.
ATE311373T1 (en) OXADIAZOLE COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE INGREDIENTS
BR0014381A (en) Derivatives of 5-beta-sapogenin and pseudosapogenin and their use in the treatment of dementia
YU13301A (en) Muscarinic agonists and antagonists
DK1228097T3 (en) Antimicrobial activity of the first cationic human lactoferrin cluster
DK1189615T3 (en) Endoparasiticide synergistic combination containing cyclic depsipeptides and piperazines
TR200402070T4 (en) Cyclobutene-dione derivatives and their use in the treatment of arteriosclerosis
NO961204L (en) Triarylethylene derivatives for use in therapy
NO20021429L (en) 1,4-dioxacycloalkan-2-one and 1,4-dioxacycloalken-2-one
UA37545A (en) POTASSIUM SALT of N-(1,4-DIOXO-3-METHYL-1,4-DIHYDRONAPHTh-2-YL) GLYCINE, REVEALING anti -hypoxic and anti-ischemic action